Times, they are a-changing.
The outcome of the US elections in the fall of 2002 serve as symbol of the high degree of change currently affecting the fate of people with HIV. The political and economic environment raises serious concerns about the future of treatment access, support for medical care and the overall priority given the fight against HIV within the federal government. HIV programs, with the exception of research at the National Institutes of Health, have not seen increases in the President's budget since the current administration took office, despite obvious increases in demand. The recent election gives little reason to think that will change. Not only are different attitudes affective every aspect of HIV funding, but different people, with different agendas, have significant influence over federal HIV policy.
D019380:Anti-HIV Agents / Q000008:administration & dosage / Q000627:therapeutic use; D005380:Financing, Government; D015658:HIV Infections / Q000188:drug therapy; D006801:Humans; D007356:Insurance, Pharmaceutical Services; D011057:Politics
D019380:Anti-HIV Agents